Hikma Pharmaceuticals (LON:HIK) Insider Laura Balan Balan Purchases 3,500 Shares

Hikma Pharmaceuticals PLC (LON:HIK) insider Laura Balan Balan bought 3,500 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was purchased at an average price of GBX 1,821 per share, for a total transaction of £63,735.

Hikma Pharmaceuticals Stock Up 0.8%

Shares of Hikma Pharmaceuticals stock opened at GBX 1,836 on Friday. The company has a debt-to-equity ratio of 55.82, a quick ratio of 1.27 and a current ratio of 1.66. Hikma Pharmaceuticals PLC has a 52-week low of GBX 1,690 and a 52-week high of GBX 2,360. The stock has a market capitalization of £5.09 billion, a price-to-earnings ratio of 18.02, a P/E/G ratio of 2.38 and a beta of 0.41. The company’s 50 day moving average price is GBX 1,947.60 and its 200-day moving average price is GBX 2,021.63.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on HIK shares. JPMorgan Chase & Co. cut their target price on shares of Hikma Pharmaceuticals from GBX 2,600 to GBX 2,500 and set an “overweight” rating on the stock in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Hikma Pharmaceuticals from GBX 3,100 to GBX 2,850 and set a “buy” rating on the stock in a report on Tuesday, August 12th. Finally, Jefferies Financial Group restated a “buy” rating and issued a GBX 2,600 target price on shares of Hikma Pharmaceuticals in a report on Thursday, August 7th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Hikma Pharmaceuticals presently has an average rating of “Buy” and a consensus price target of GBX 2,627.50.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.